Search results | vaccine

Reports

Infectious Vaccines Partnering Terms and Agreements

The Infectious Vaccines Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter infectious vaccines partnering deals.

Vaccine Partnering Terms and Agreements

The Vaccine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the vaccine partnering deals and agreements entered into by the worlds leading healthcare companies

Cancer Vaccine Partnering Agreements

The Cancer Vaccine Partnering Agreements report provides an understanding and access to the cancer vaccine partnering deals and agreements entered into by the worlds leading healthcare companies

Diagnostic Imaging Partnering Terms and Agreements

The Diagnostic Imaging Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the diagnostic imaging partnering agreements entered into by the worlds leading healthcare companies.

Insights

Industry trends in vaccine dealmaking – 2009 to 2014

Industry trends suggest that vaccine research and development is an increasingly active component of healthcare business development. In recent years there has been a significant increase in vaccine partnering and M&A activity.

Trends analysis: Cancer vaccine partnering on the rise

Recent trends analysis suggests that research in personalized medicine and vaccine development for disease treatment has increased partnering and collaboration in this arena.

Vaccine partnering

A vaccine is a biological preparation that improves immunity to a particular disease.

Industry trends in infectious vaccines dealmaking – 2009 to 2014

Industry trends suggest that infectious vaccines research and development is an increasingly active component of healthcare business development. The last decade has witnessed a significant number of infectious vaccines partnering and M&A activity

Cancer vaccine

A cancer vaccine is a vaccine that treats existing cancer or prevents the development…

Infectives vaccine partnering

A vaccine is a biological preparation that improves immunity to a particular disease

Ranbaxy Laboratories also looking to sell its vaccine business

Drug maker Ranbaxy Laboratories is likely to sell off Biovel, a Bangalore-based vaccine manufacturing company which it had acquired in 2010.

CSL: Protecting patients globally with vaccines and plasma products

CSL is a large speciality biopharmaceutical company developing and manufacturing plasma products and vaccines to treat and protect patients worldwide.

Dealtalk: Novartis said to want out of Indian vaccines venture

In dealtalk, Novartis plans to exit an eight-year-old vaccines joint venture with India’s Panacea Biotec and intends to go it alone.

Pharma rumor mill: GlaxoSmithKline forges ahead with hunt for Chinese vaccine partners

In the pharma rumor mill: GlaxoSmithKline may be suffering through a corruption scandal in China, but that hasn’t interfered with its plans to team up with a Chinese company on vaccines.

Events

Sorry, your search returned no results.


Deals

Janssen and Ichor Medical enter hep B vaccine delivery alliance

Ichor Medical Systems has entered into a product development collaboration and worldwide license agreement with Janssen Pharmaceuticals

Sanofi Pasteur and VBI Vaccines in formulation pact

VBI Vaccines has entered into a research collaboration with Sanofi Pasteur to apply VBI’s LPV (Lipid Particle Vaccine) formulation technology

GSK announces grant to IAVI for human vaccines project

The International AIDS Vaccine Initiative has received a grant of US$350,000 from GSK to support implementation of the Human Vaccines Project,

Astellas licenses allergy vaccine from Immunomic

Immunomic Therapeutics and Astellas Pharma have entered into an exclusive license agreement for Japan to develop and commercialize JRC2-LAMP-vax

Merck licenses Moderna’s RNA-based antiviral vaccines and passive immunity therapies

Moderna Therapeutics announced a license and collaboration agreement with Merck for the discovery and development of vaccines and passive immunity treatments against viral diseases

Pfizer acquires Redvax, gains promising CMV vaccine candidate

Pfizer has acquired a controlling interest in Redvax

Vaccinex and Janssen in cancer collaboration

Vaccinex has entered into a research collaboration with Janssen Research & Developmentfor the creation of novel anti-cancer agents

Merck and Newlink ink Ebola vaccine deal

Merck and NewLink Genetics have entered into an exclusive worldwide license agreement to research, develop, manufacture, and distribute NewLink’s investigational rVSV-EBOV (Ebola) vaccine candidate

CSL has acquired the Flu vaccine business from Novartis

Novartis announced has entered an agreement that CSL has acquired its influenza vaccine business in a $275 million deal that will require regulatory approval before it closes by the end of the second half of 2015.

GSK and J&J are pharma partnering for Ebola vaccine

GlaxoSmithKline and Johnson & Johnson will become pharma partnering for increasing production of an Ebola vaccine, with an aim to produce at least 1 million doses next year.